Question 1

Which countries lead Multiple and Secondary Primary Cancers research?

Accepted Answer

By volume, the United States and China publish the most (1.2k and 823 works in 2022-now).

Question 2

Which institutions lead Multiple and Secondary Primary Cancers research?

Accepted Answer

By volume in 2022-now, Harvard University publishes the most Multiple and Secondary Primary Cancers research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Sun Yat-sen University.

Question 3

Who are the leading researchers in Multiple and Secondary Primary Cancers?

Accepted Answer

The most-cited researchers publishing on Multiple and Secondary Primary Cancers include Ahmedin Jemal, Christopher J L Murray and Rebecca L. Siegel.

Question 4

Where is Multiple and Secondary Primary Cancers research done?

Accepted Answer

The largest centres of Multiple and Secondary Primary Cancers research in 2022-now are Beijing (China), Tokyo (Japan), New York (United States) and Shanghai (China).

Question 5

Where is the best place to study Multiple and Secondary Primary Cancers?

Accepted Answer

Among universities, judged by research, Harvard University, Chinese Academy of Medical Sciences & Peking Union Medical College and University of Utah score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Question 6

Is Multiple and Secondary Primary Cancers research growing?

Accepted Answer

Output in 2022-2025 was 5% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Multiple and Secondary Primary Cancers.

Question 7

What are the most cited papers in Multiple and Secondary Primary Cancers?

Accepted Answer

The most cited paper in Multiple and Secondary Primary Cancers is "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries" (Hyuna Sung, Adalberto M. Filho, Mathieu Laversanne et al., 2021), with 114,522 citations. Next come "Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012" (29,250) and "Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" (25,936).